Literature DB >> 24225260

Serum prolidase enzyme activity and oxidative status in patients with Behçet's disease.

Mehtap Bozkurt, Hatice Yüksel, Serda Em, Pelin Oktayoglu, Mehmet Yildiz, Dicle Akdeniz, Kemal Nas.   

Abstract

OBJECTIVES: To assess serum prolidase enzyme activity and oxidative stress in patients with Behçet's disease (BD).
METHODS: The study population consisted of BD patients (n = 42) and healthy participants (n = 29). BD patients were classified as active (n = 18) or inactive (n = 24) according to disease activity. Serum prolidase enzyme activity, total antioxidant status (TAS), total oxidative status (TOS), oxidative stress index (OSI), and malondialdehyde (MDA) levels were measured.
RESULTS: In BD patients with active disease, serum prolidase activity was significantly higher compared with the inactive and control participants. Serum prolidase activity was also significantly higher in all BD patients in comparison with controls. Serum prolidase activity was also positively correlated with OSI, C-reactive protein, and active BD. MDA, TOS, and OSI levels were all significantly higher in the BD group when compared with the healthy control participants. Serum TAS levels were significantly lower in BD patients in comparison with healthy controls.
CONCLUSION: High prolidase activity may indicate critical biological activities relevant to pathological events in BD, and this activity may be a biological indicator of disease. Further studies are needed to verify these findings.

Entities:  

Keywords:  Behçet disease; Oxidative status; Prolidase

Mesh:

Substances:

Year:  2013        PMID: 24225260      PMCID: PMC6837555          DOI: 10.1179/1351000213Y.0000000072

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  46 in total

1.  Arthropathy, quality of life, depression, and anxiety in Behcet's disease: relationship between arthritis and these factors.

Authors:  Ali Gur; Aysegul Jale Sarac; Yahya Kemal Burkan; Kemal Nas; Remzi Cevik
Journal:  Clin Rheumatol       Date:  2006-04-26       Impact factor: 2.980

2.  The serum vitamin C levels in Behçet's disease.

Authors:  Tevfik Noyan; Idris Sahin; M Ramazan Sekeroğlu; Haluk Dülger
Journal:  Yonsei Med J       Date:  2003-10-30       Impact factor: 2.759

3.  Serum prolidase activity in psoriasis patients.

Authors:  Berrak Guven; Murat Can; Mehmet Genc; Rafet Koca
Journal:  Arch Dermatol Res       Date:  2013-04-04       Impact factor: 3.017

4.  Collagen metabolism disturbances are accompanied by an increase in prolidase activity in lung carcinoma planoepitheliale.

Authors:  E Karna; A Surazynski; J Palka
Journal:  Int J Exp Pathol       Date:  2000-10       Impact factor: 1.925

5.  Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease.

Authors:  Fuat Erdem; Mehmet Gündoğdu; Ilhami Kiki; Refik Ali Sari; Ahmet Kiziltunç
Journal:  Rheumatol Int       Date:  2004-07-15       Impact factor: 2.631

6.  Iminodipeptiduria: a genetic defect in recycling collagen; a method for determining prolidase in erythrocytes.

Authors:  S H Jackson; A W Dennis; M Greenberg
Journal:  Can Med Assoc J       Date:  1975-10-18       Impact factor: 8.262

7.  Increased advanced oxidation protein products in Behçet's disease: a new activity marker?

Authors:  C Yazici; K Köse; M Caliş; M DemIr; M Kirnap; F Ateş
Journal:  Br J Dermatol       Date:  2004-07       Impact factor: 9.302

8.  Lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.

Authors:  R Sandikci; S Türkmen; G Güvenen; H Ayabakan; P Gülcan; M Koldas; Z Ozbek Kir; N Yenice
Journal:  Acta Derm Venereol       Date:  2003       Impact factor: 4.437

9.  Trace elements and antioxidant enzymes in Behçet's disease.

Authors:  K Saglam; A F Serce; M I Yilmaz; F Bulucu; A Aydin; C Akay; A Sayal
Journal:  Rheumatol Int       Date:  2002-05-18       Impact factor: 2.631

10.  Decreased total antioxidant response and increased oxidative stress in Behcet's disease.

Authors:  Ahmet Isik; Suleyman Serdar Koca; Bilal Ustundag; Sahabettin Selek
Journal:  Tohoku J Exp Med       Date:  2007-06       Impact factor: 1.848

View more
  6 in total

1.  Serum prolidase activity in systemic sclerosis.

Authors:  Ahmet Celik; Muhammed Nur Birer; Metin Kilinc
Journal:  Clin Rheumatol       Date:  2017-05-22       Impact factor: 2.980

2.  Levels of F2 isoprostane in Behcet's disease: Correlation with cardiometabolic risk factors.

Authors:  Gul Sagun; Aytekin Oguz; Banu Mesci; Banu Isbilen; Mukaddes Kavala; Havva Keskin; Mumtaz Takir; Sibel Zehra Aydin
Journal:  Redox Rep       Date:  2015-04-13       Impact factor: 4.412

3.  Serum prolidase level in ankylosing spondylitis: low serum levels as a new potential gold standard biomarker for disease activity.

Authors:  Sevgi Baspinar; Mehmet Kırnap; Osman Baspınar; Oguzhan Sıtkı Dizdar; Derya Kocer
Journal:  Rheumatol Int       Date:  2016-07-21       Impact factor: 2.631

4.  Cytomorphometric Characteristics of Buccal Mucosal Cells in Behçet's Disease Patients.

Authors:  Erol Aktunc; Zehra Safi Oz; Sibel Bektas; Cevdet Altinyazar; Rafet Koca; Serdar Bostan
Journal:  Anal Cell Pathol (Amst)       Date:  2016-03-21       Impact factor: 2.916

Review 5.  Emerging Roles of Redox-Mediated Angiogenesis and Oxidative Stress in Dermatoses.

Authors:  Dehai Xian; Jing Song; Lingyu Yang; Xia Xiong; Rui Lai; Jianqiao Zhong
Journal:  Oxid Med Cell Longev       Date:  2019-04-16       Impact factor: 6.543

6.  Prolidase Enzyme Activity in Conjunctiva and Pterygium Tissues.

Authors:  Yıldıray Yıldırım; Abdullah Kaya; Taner Kar; Tuba Muftuoglu; Ali Ayata
Journal:  Med Sci Monit       Date:  2015-10-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.